VERICEL CORPORATION Liabilities, Noncurrent
VERICEL CORPORATION (VCEL) had Liabilities, Noncurrent of $1.67 million as of 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2019-02-26
- 2018-12-31: Liabilities, Noncurrent $1.67M.
- 2017-12-31: Liabilities, Noncurrent $2.06M.
- 2016-12-31: Liabilities, Noncurrent $1.69M.
- 2015-12-31: Liabilities, Noncurrent $0.00; Liabilities, Noncurrent as first filed $71.00K.
| Period end | Liabilities, Noncurrent | Liabilities, Noncurrent as first filed |
|---|---|---|
| 2018-12-31 | $1.67M 10-K · filed 2019-02-26 | |
| 2017-12-31 | $2.06M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $1.69M 10-K · filed 2018-03-05 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-13 | $71.00K 10-K · filed 2016-03-14 |
| 2014-12-31 | $109.00K 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |